About CanniMed Therapeutics (TSE:CMED)
CanniMed Therapeutics Inc is a Canada-based plant biopharmaceutical company. It is specialized in the production of pharmaceutical-grade cannabis and offers a range of pharmaceutical-grade cannabis products. In addition, the Company has a plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications. The Company, through its subsidiary CanniMed Ltd, offers medical cannabis oils, dried medical cannabis, vaporizers, vaporizer parts and accessories. Its CanniMed Oils are made using only dried cannabis flowers. Its vaporizers include Arizer Air vaporizer and Volcano Medic vaporizer. Its vaporizer parts and accessories include ARIZER AIR All Glass Tube (no mouthpiece), ARIZER AIR Charger/Power Adapter, ARIZER AIR Dual Battery Charger, ARIZER AIR Glass Tube with black mouthpiece, ARIZER AIR Replacement Battery, Volcano Medic Air Filter Cap and Volcano Medic Air Filter Set.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-5.96%
Return on Assets-4.95%
CanniMed Therapeutics (TSE:CMED) Frequently Asked Questions
What is CanniMed Therapeutics' stock symbol?
CanniMed Therapeutics trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CMED."
Who are some of CanniMed Therapeutics' key competitors?
Some companies that are related to CanniMed Therapeutics include ProMetic Life Sciences (PLI), Valener (VNR), Avigilon (AVO), SunOpta (SOY), Baytex Energy (BTE), Canfor Pulp Products (CFX), Sierra Wireless (SW), Real Matters (REAL), Nevsun Resources (NSU), DREAM Unlimited (DRM), Ag Growth International (AFN), Brookfield Canada Office Properties (BOX.UN), Jamieson Wellness (JWEL), Morguard Real Estate Inv. (MRT.UN), Ainsworth Lumber (ANS), Novadaq Technologies (NDQ), Fiera Capital (FSZ) and Extendicare (EXE).
Who are CanniMed Therapeutics' key executives?
CanniMed Therapeutics' management team includes the folowing people:
- Donald R. Ching, Independent Chairman of the Board (Age 74)
- Brent Zettl, President, Chief Executive Officer, Director (Age 54)
- John L. Knowles, Chief Financial Officer, Corporate Secretary, Director (Age 61)
- Gulwant Bajwa, Vice President - Business Development and Regulatory Affairs (Age 54)
- Larry Holbrook, Chief Research Officer (Age 69)
- Douglas W. Banzet, Independent Director (Age 66)
- Rob Duguid, Independent Director (Age 52)
- Marianne Greer Ph.D., Independent Director (Age 63)
- Richard Hoyt, Independent Director (Age 63)
- Dwayne Lawrence Lashyn, Independent Director (Age 52)
How do I buy CanniMed Therapeutics stock?
Shares of CanniMed Therapeutics and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is CanniMed Therapeutics' stock price today?
One share of CanniMed Therapeutics stock can currently be purchased for approximately C$19.88.
How big of a company is CanniMed Therapeutics?
CanniMed Therapeutics has a market capitalization of C$472.79 million.
How can I contact CanniMed Therapeutics?
CanniMed Therapeutics' mailing address is 1 Plant Technology Road, Box 19A, Rr#5, SASKATOON, SK S7K 3J8, Canada. The company can be reached via phone at +1-306-9751207.
MarketBeat Community Rating for CanniMed Therapeutics (CMED)MarketBeat's community ratings are surveys of what our community members think about CanniMed Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
CanniMed Therapeutics (TSE:CMED) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Earnings History for CanniMed Therapeutics (TSE:CMED)
No earnings announcements for this company have been tracked by MarketBeat.com
CanniMed Therapeutics (TSE:CMED) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for CanniMed Therapeutics (TSE:CMED)
No dividend announcements for this company have been tracked by MarketBeat.com
CanniMed Therapeutics (TSE CMED) Insider Trading and Institutional Ownership History
CanniMed Therapeutics (TSE CMED) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|7/13/2017||Saskworks Venture Fund Inc.||Insider||Buy||126,500||C$8.35||C$1,056,275.00|
|7/7/2017||Saskworks Venture Fund Inc.||Insider||Buy||21,500||C$8.14||C$175,010.00|
|6/28/2017||Brenton Harold Zettl||Director||Buy||7,300||C$7.99||C$58,327.00|
|6/27/2017||Brenton Harold Zettl||Director||Buy||7,300||C$7.99||C$58,327.00|
|6/15/2017||Brenton Harold Zettl||Director||Buy||50,000||C$7.91||C$395,500.00|
CanniMed Therapeutics (TSE CMED) News Headlines
|Ontario regulator to hear Aurora, CanniMed cases on Dec. 20|
finance.yahoo.com - December 13 at 5:59 PM
|Aurora Cannabis wins rights for licensing talks with CannaRoyalty|
finance.yahoo.com - December 13 at 9:14 AM
|CanniMed asks Canadian regulators to intervene in hostile Aurora bid|
www.reuters.com - December 12 at 6:20 PM
|Canadian regulator schedules hearing on CanniMed-Aurora takeover battle|
finance.yahoo.com - December 12 at 6:20 PM
|PRESS DIGEST-Canada-Dec 12|
finance.yahoo.com - December 12 at 9:25 AM
|CanniMed Commences Legal Action against the Aurora Hostile Bid; Files Proxy and Directors' Circulars; Urges ... - Business Wire (press release)|
www.businesswire.com - December 11 at 9:40 AM
|CanniMed Commences Legal Action against the Aurora Hostile Bid; Files Proxy and Directors’ Circulars; Urges Shareholders to Vote Their Green Proxy in Favour of the Newstrike Acquisition, and to Take No Action to Reject Aurora’s Hostile Bid|
finance.yahoo.com - December 11 at 9:40 AM
|Actions Versus Words: Aurora CEO’s Actions Reveal That Aurora Stock is Inflated; Insiders Sell $17 Million in Stock During Their Hostile Take-over Bid for CanniMed and During a Financing|
finance.yahoo.com - November 30 at 5:46 PM
|MEDIA ADVISORY: CanniMed Therapeutics Inc. and Up Cannabis Inc. (Newstrike Resources Ltd. – TSX-V:HIP) Announce Webcast and Conference Call to Discuss Plans for Creating a ...|
www.businesswire.com - November 20 at 6:22 PM
|CanniMed to Acquire Up Cannabis Inc. (Newstrike Resources Ltd. – TSX-V:HIP) to Create a Premier Global Cannabis Company|
www.businesswire.com - November 17 at 9:33 PM
|CanniMed to Acquire Up Cannabis Inc. (Newstrike Resources Ltd. - TSX-V: HIP) to Create a Premier Global Cannabis Company|
finance.yahoo.com - November 17 at 9:33 PM
|Update: TSX Posts First Gain of the Week, Rising 56 Points, Boosted by Financial Issues - Nasdaq|
www.nasdaq.com - November 17 at 11:08 AM
|CanniMed Acknowledges Aurora Press Release and Announces Exclusivity Agreement and Intention to Acquire Newstrike Resources Ltd.|
www.businesswire.com - November 16 at 12:54 PM
|Aurora Cannabis Submits Proposal to CanniMed Therapeutics Board|
finance.yahoo.com - November 14 at 10:55 PM
|CanniMed Therapeutics Inc. Receives License from Health Canada to Produce Medical Cannabis Capsules|
finance.yahoo.com - October 16 at 6:04 PM
|CanniMed Therapeutics Inc (CMED) Insider Larry Holbrook Sells 5,000 Shares|
www.americanbankingnews.com - October 5 at 8:08 PM
|CanniMed Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CMED-CA : October 3, 2017|
finance.yahoo.com - October 3 at 5:08 PM
|CanniMed Therapeutics, Inc. – Value Analysis (TORONTO:CMED) : September 19, 2017|
finance.yahoo.com - September 19 at 10:24 PM
|CanniMed Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CMED-CA : September 18, 2017|
finance.yahoo.com - September 18 at 5:19 PM
|CanniMed Therapeutics Inc. Adds to Executive Leadership Team - Business Wire (press release)|
www.businesswire.com - September 14 at 11:06 PM
|CanniMed Therapeutics Inc. Adds to Executive Leadership Team|
finance.yahoo.com - September 14 at 6:05 PM
|CanniMed Therapeutics Inc. Reports Financial Results for Q3 2017|
www.businesswire.com - September 11 at 6:00 PM
|CanniMed Therapeutics Inc. Announces 2017 Third Quarter Results Release Date - Business Wire (press release)|
www.businesswire.com - September 7 at 3:27 AM
|CanniMed Therapeutics Inc. Announces 2017 Third Quarter Results Release Date|
finance.yahoo.com - September 5 at 6:53 PM
|CanniMed Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : CMED-CA : August 25, 2017|
finance.yahoo.com - August 25 at 7:05 PM
|CanniMed Therapeutics, Inc. – Value Analysis (TORONTO:CMED) : July 31, 2017|
finance.yahoo.com - July 31 at 10:13 PM
|Saskworks Venture Fund Inc. Acquires 126,500 Shares of CanniMed Therapeutics Inc (TSE:CMED) Stock|
www.americanbankingnews.com - July 18 at 7:25 PM
|CanniMed Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CMED-CA : July 14, 2017|
finance.yahoo.com - July 14 at 7:19 PM
|CanniMed Therapeutics Inc (TSE:CMED) Insider Purchases C$175,010.00 in Stock|
www.americanbankingnews.com - July 13 at 5:06 PM
CanniMed Therapeutics (TSE:CMED) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
CanniMed Therapeutics (TSE CMED) Stock Chart for Thursday, December, 14, 2017